Novartis acquires AveXis, including the AVXS-101 treatment for SMA
Pfizer and Allogene to collaborate on developing donor-derived CAR T-cell therapies
Orchard Therapeutics acquires GSK rare disease gene therapy portfolio
Pfizer launching phase 1b trial of gene therapy for Duchenne muscular dystrophy
Personalised cancer vaccine directs T-cell response to ovarian cancer
Goldman Sachs report highlights need for gene therapy pricing strategy
Clinical trial shows gene therapy for beta-thalassemia is safe and effective
Trial of CRISPR to treat beta-thalassemia to start in Europe
GE launching prefabricated manufacturing units for producing virus-based gene and cell therapies
CRISPR-Cas9 genome editing - molecular scissors a bit too sharp?
Grégoire Cullot received the ESGCT-sponsored prize for best oral presentation at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about his winning presentation here!
Dgkk as a new therapeutic target in the Fmr1-KO murine model of Fragile X
Karima Habbas received the ESGCT-sponsored prize for best poster at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about her winning presentation here!
Hellenic Society of Gene Therapy and Regenerative Medicine - 4th Congress
Spring School 2019 Report
Copyright ©2016 European Society of Gene and Cell Therapy | Website by OFEC